Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2025-12-28 @ 11:31 PM
Study NCT ID:
NCT01693692
Status:
COMPLETED
Last Update Posted:
2022-03-04
First Post:
2012-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Sponsor:
Theravance Biopharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0092
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None